June 21, 2012 โ TriReme Medical Inc. announced today it received U.S. Food and Drug Administration (FDA) clearance for ...
Balloon Catheter
This channel includes news and new technology innovations for angioplasty balloon catheters (PTA). These are used in arteries with atherosclerotic lesions to compress the plaque expand the artery lumen to reopen occluded or heavily stenosed atherosclerotic lesions. Balloons are often used in combination with a stent to prop the treated vessel segment open. In addition to plain old balloon angioplasty (POBA), this section includes news about drug-coated balloon (DCB), valvuloplasty balloons and specialty cutting balloon.
June 13, 2012 โ Physicians presented at EuroPCR 2012 the results of two multicenter, randomized controlled trials, the ...
June 13, 2012
May 30, 2012 โ Boston Scientific Corp. announces the U.S. Food and Drug Administration has cleared an expanded use ...
May 30, 2012Sponsored Content
Case Study | Baylor Scott and White Heart Hospital
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 05, 2023
May 23, 2012 - TriReme Medical Inc. announced approval by the U.S. Food and Drug Administration (FDA) of the Glider PTCA ...
May 23, 2012
May 4, 2012 - Angioslide Ltd., a provider of embolic capture angioplasty solutions, announced that it has received U.S ...
May 04, 2012May 4, 2012 - A new balloon catheter system could advance the endovascular approach to treating obstructed arteries in ...
May 04, 2012April 24, 2012 - Boston Scientific Corp. announces CE mark and European market launch of the Emerge PTCA Dilatation ...
April 24, 2012
April 17, 2012 โโ Expanding its commitment to developing innovative treatments for cardiovascular disease and the ...
April 17, 2012
March 20, 2012 - MarBlue Medical announced the global product launch of its CE-marked drug-eluting balloon (DEB) Protege ...
March 20, 2012
January 25, 2012 โ Physicians at University Hospitals (UH) Case Medical Center enrolled their first patient in LEVANT 2 ...
January 25, 2012
January 6, 2012 - C. R. Bard recently announced it acquired drug-eluting balloon maker Lutonix Inc. for $225 million ...
January 06, 2012December 28, 2011 โ Good Samaritan Hospital in Los Angeles is participating in the Levant 2 clinical trial to ...
December 28, 2011
December 15, 2011 โ Neovasc Inc. announced it has received the CE mark designation for its Reducer product for the ...
December 15, 2011
December 13, 2011 โ Boston Scientific announced the U.S. launch of its Charger PTA Balloon Catheter, a 0.035-inch ...
December 13, 2011November 15, 2011 โ Results from the PROFI study indicate that the use of a proximal balloon occlusion in carotid artery ...
November 15, 2011ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now